Clinical trials: Methamphetamine Intoxication
Methamphetamine Intoxication, Methamphetamine Disorders
A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine
The purpose of the study is to evaluate the safety, efficacy, and pharmacokinetics of four single, increasing doses of CS-1103, given by intravenous (IV) infusion in otherwise healthy, non-treatment seeking participants with…
- Conditions
- Methamphetamine Intoxication, Methamphetamine Disorders, Methamphetamine Abuse
- Trial name
- NCT06721494
- Testing
- Methamphetamine, Sterile Saline, CS-1103
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- Clear Scientific, Inc.
Substance Use Disorders, Methamphetamine Abuse
A Clinical Study to Evaluate the Safety of CS-1103 in Healthy Participants
The purpose of this Phase 1a study is to evaluate safety, tolerability, and pharmacokinetics (PK) of single, ascending doses of CS-1103, administered by intravenous (IV) infusion in healthy participants.
- Conditions
- Substance Use Disorders, Methamphetamine Abuse, Methamphetamine Intoxication
- Trial name
- NCT06316973
- Testing
- CS-1103, Sterile Saline
- Where
- United States
- Volunteers
- 32 people, healthy volunteers welcome
- Sponsor
- Clear Scientific, Inc.
Methamphetamine Intoxication (Disorder)
Meth-OD: A Study of IXT-m200 in Patients With Toxicity From Methamphetamine Overdose
The hypothesis of this multisite Phase 2a study is that IXT-m200 will be well-tolerated in patients with acute mild to moderate METH toxicity.
- Trial name
- Meth-OD (NCT04715230)
- Testing
- IXT-m200, Lorazepam, Haloperidol
- Where
- 4 sites in United States
- Volunteers
- 20 people
- Sponsor
- InterveXion Therapeutics, LLC